Vital Signs - Healthcare News - The Analysts Perspective February 2014 Issue

Vital Signs - Healthcare News - The Analysts Perspective February 2014 Issue

RELEASE DATE
28-Feb-2014
REGION
North America
Research Code: 9A35-00-0C-00-00
SKU: LS00219-NA-MR_17497

$450.00

Special Price $337.50 save 25 %

In stock
SKU
LS00219-NA-MR_17497

$450.00

$337.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This issue of Vital Signs, released on February 28, 2014, discusses three M&A transactions this month by Nestle, Myriad Genetics, and Fludigm' and what these deals mean for the industry. Additionally, Illumina's first stab at personalized medicine through a partnership with Amgen is explored.

Table of Contents

This week's issue